Eating disorders (ED) represent a serious mental problem among adolescent and young adult women (Society for Adolescent Medicine, 1995) . Both individuals with anorexia nervosa (AN) and with bulimia nervosa (BN) are at risk for developing serious, and often chronic health and mental health problems (for review, see Pike and StriegelMoore, 1997) . The onset of eating disorder symptoms typically occurs during adolescence. Unfortunately, there is relatively little information about the epidemiology of ED in community-based adolescents.
In this report we take advantage of a data set based on a large sample of randomly selected high school students who entered an epidemiological study, the Oregon Adolescent Depression Project (OADP), and who were reexamined a year later (Lewinsohn et al., 1993) and again during their 24th year (Lewinsohn et al., 1999) . On each of these occasions, extensive diagnostic information was collected about current and past episodes of mental disorders which included aspects of problematic eating behaviors. In a previous publication (Lewinsohn et al., 1993) we provided information about the point and lifetime prevalence of AN and BN in female and male adolescents. The lifetime prevalence rate of ED for female adolescents was 23 per 1,000 compared with 1.4 per 1,000 for male adolescents. Given the extremely low base rate for the male sample, the purpose of this report is to extend the findings of the female sample by addressing 3 major issues.
First, with important exceptions (e.g., Whitaker et al., 1990) , existing epidemiological studies have focused primarily on adult populations. Information regarding the epidemiology of ED in community-residing adolescent populations is needed to better inform public health policy regarding the allocation of resources to prevention efforts and mental health services.
Second, several influential investigators have suggested that the diagnostic thresholds of the DSM-IV (American Psychiatric Association, 1994) for AN and BN are too high and that subthreshold or partial-syndrome (PS-ED) cases be included in studies of ED (e.g., Garfinkel et al., 1995a) . PS-ED cases typically have been defined by refusal to maintain adequate (85% of normal) body weight for AN and by the presence of recurrent binge eating for BN without sufficient other ED symptoms to meet criteria for diagnosis. A substantial proportion of patients presenting for treatment for ED are PS-ED cases (e.g., Bunnell et al., 1990) . Studies that have compared full-syndrome (FS-ED) with PS-ED cases have found few differences on clinical and psychosocial characteristics (Kendler et al., 1991) . Moreover, in a small case series of patients requesting treatment who were followed over time, about half of women with PS-ED were found to ultimately develop a full-syndrome disorder (Herzog et al., 1993) . Thus, the second goal of this study is to examine the clinical characteristics and natural course of PS-ED in an adolescent community sample.
Finally, most research on the natural course of ED has been based on adult patient samples of women seeking treatment at tertiary treatment centers. These studies have found that for many patients, AN and BN take a chronic course (for review see Herzog et al., 1992) . Little is known about the long-term course of child and adolescent ED and its continuity with adult ED. A recent study of the 10-to 15-year outcome of AN in a sample of adolescent patients reported more favorable outcome data than the adult outcome studies. Specifically, by the end of the study 76% of patients were fully recovered. Recovery, however, was a protracted process requiring on average about 80 months (Strober et al., 1997) . It is unclear whether the protracted course observed among both adolescent and adult patients and the relatively poor longterm prognosis reported for adult patients are, in large part, a function of selection biases. Only a minority of individuals with an eating disorder enter mental health treatment (Turnbull et al., 1996) . Thus, the third goal of the study is to provide information on longitudinal course and continuity between childhood/adolescent ED and young adult psychopathology (age 19-23) based on a community sample.
METHOD

Participants
Participants were randomly selected from 9 senior high schools in western Oregon who completed initial assessments (T 1 ; n = 1,709) between 1987 and 1989 . Approximately 1 year later, 1,507 of the participants (88%) returned for the readministration of the interview and questionnaire. Statistically significant differences between participants and those who declined to participate and those who dropped out of the study before T 2 were small (additional details are provided by Lewinsohn et al., 1993) .
As OADP participants reached their 24th birthday, all participants with a history of major depressive disorder (MDD) (n = 360) or with a history of nonmood disorder (including ED; n = 284) at T 2 , and a randomly selected subset of adolescents with no psychiatric diagnosis by T 2 (n = 457), were invited to participate in a T 3 interview. Of the T 2 participants selected for T 3 interview (n = 1,101), data are available for 940 (85%) individuals. The T 2 diagnostic groups did not differ in the rate of participation at T 3 . The reference sample for the present study was restricted to female participants (T 1 , n = 891; T 2 , n = 810; T 3 , n = 538). PS-ED and FS-ED were not significantly associated with attrition from T 1 to T 2 or from T 2 to T 3 .
Diagnostic Interviews
Participants were interviewed at T 1 with a version of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS), which combined features of the Epidemiologic version (Orvaschel et al., 1982) and the Present Episode version and included additional items to derive DSM-III-R diagnoses (American Psychiatric Association, 1987) . At T 2 and T 3 , participants were interviewed with the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987) , which elicited detailed information about the course of psychiatric symptoms and disorders since the previous interview. Preliminary T 3 data indicated that the rates of most Axis II personality disorders in our community sample of young adults were extremely low. Therefore, only the 2 most frequent DSM-IV personality disorders (antisocial and borderline) were assessed, using relevant portions of the Personality Disorder Examination (PDE) (Loranger, 1988) . T 3 interviews were conducted by telephone, and diagnoses were made according to DSM-IV criteria.
Diagnostic interviewers were carefully selected and trained. Based on a randomly selected subsample at T 1 (n = 233), interrater reliability for lifetime diagnoses were moderate to excellent: bipolar disorder (κ = 0.49), manic core symptom (κ = 0.57), MDD (κ = 0.86), dysthymia (κ = 0.58), anxiety disorders (κ = 0.76), disruptive behavior disorders (κ = 0.83), alcohol abuse/dependence (κ = 0.84), and drug abuse/ dependence (κ = 0.84). For the T 2 -T 3 period (n = 178), interrater reliability was moderate to excellent for eating disorder (κ = 0.66), bipolar disorder (κ = 0.74), MDD (κ = 0. 86), anxiety (κ = 0.87), alcohol abuse/dependence (κ = 0.77), and drug abuse/dependence (κ = 0.94). The interrater reliability of the PDE dimensional scores (i.e., summation of partial and full symptom criteria) was excellent (intraclass correlation coefficient [2,1] > 0.80).
PS-ED and FS-ED.
Although initially designed to collect diagnostic information according to DSM-III-R, enough information was collected in the T 1 and T 2 assessments to ascertain the AN and BN symptom patterns for DSM-IV criteria. Reclassification to DSM-IV criteria was accomplished by reviewing the interview packets and summary write-ups. PS-AN was defined as meeting the DSM-IV criterion A (i.e., refusal to maintain body weight at or above a minimally normal weight for age and height) plus 1 of the additional 3 symptoms (criterion B, C, or D). PS-BN was defined as meeting the DSM-IV criterion A (i.e., recurrent episodes of binge eating) plus 1 of the additional 3 symptoms (criterion B, C, or D), not including criterion E (i.e., the disturbance does not occur exclusively during episodes of AN).
Other Psychopathology During Adolescence. To examine the extent to which PS-ED and FS-ED co-occur with other psychiatric disorders, the T 2 lifetime occurrence of the following disorders was examined: unipolar depression (n = 267; major depression, n = 256; dysthymia, n = 33), bipolar disorder (n = 8), subthreshold bipolar disorder (n = 39; defined as having experienced a distinct period of abnormally and per-sistently elevated, expansive, or irritable mood, in addition to having one or more manic symptoms, but never having met criteria for bipolar disorder), anxiety disorder (n = 96; phobia, n = 39; separation anxiety, n = 49; overanxious, n = 16; panic, n = 12; obsessive-compulsive, n = 3), disruptive behavior disorder (n = 33; attention-deficit hyperactivity, n = 12; conduct, n = 12; oppositional defiant, n = 12), substance use disorder (n = 82; alcohol, n = 50; drug, n = 62). In addition, an aggregate measure of any disorder other than ED was included (n = 393).
Psychopathology During Young Adulthood. The period prevalence rates of psychiatric disorders were based on episodes occurring during the 19 through 23 age period. The following Axis I disorders were examined: FS-ED, PS-ED, depression, bipolar, and nonaffective (anxiety, substance use, and disruptive behavior). An aggregate measure of any disorder was also included. To examine the incidence of Axis II disorders, the PDE dimensional scores for antisocial and borderline personality disorder were dichotomized at the 90th percentile (antisocial cutoff score ≥ 7; borderline cutoff score ≥ 4).
Clinical Characteristics
Level of Functioning. Level of functioning at the time of T 2 interview was assessed using the DSM-III-R Global Assessment of Functioning (GAF) score. GAF scores could range from 1 to 90, with ratings less than or equal to 70 indicating mild symptoms or some degree of role impairment in social, school, or occupational functioning.
Depressive Symptoms. Depressive symptoms were assessed at T 2 using the 20-item Center for Epidemiologic Studies-Depression Scale (CES-D, α = .89) (Radloff, 1977) and a 14-item version of the Hamilton Depression Rating Scale (HDRS, α = .83) (Hamilton, 1960) using depression items in the K-SADS.
Mental Health Utilization. Mental health treatment utilization prior to T 2 was assessed during the diagnostic interview and was defined as receiving outpatient psychotherapy or counseling, medications, or hospitalization for a mental disorder. Twenty-nine percent received 1 to 2 treatment sessions, 27% received 3 to 7 sessions, 26% received 8 to 26 sessions, and 18% received more than 26 sessions.
History of Suicide Attempt. History of suicide attempt prior to T 2 age period was assessed during the diagnostic interview. Participants were asked, "Have you ever tried to kill yourself or done anything that could have killed you."
Other Physical Symptoms. Other physical symptoms (α = .90) consisted of the occurrence, during the previous year, of 88 physical symptoms (e.g., shortness of breath, nausea, ulcers).
Statistical Analyses
Dichotomous dependent measures were analyzed using contingencytable analysis; numeric dependent measures were analyzed using analysis of variance. Chi-square tests and odds ratios were conducted for the contrasts on dichotomous measures; t tests were conducted for the contrasts on numeric measures. To estimate the age-at-onset curves, lifetable survival methods were used. Although numerous tests were performed, thereby inflating the type 1 error rate, α was set to p < .05, 2-tailed, to identify differences of potential clinical relevance.
RESULTS
Prevalence and Incidence of Eating Disorders During Adolescence and Young Adulthood
The lifetime prevalence rates for AN and BN at each of the 3 assessments are shown in Table 1 . The lifetime prevalence rates of AN and BN are very low, ranging from 0.6% for AN at T 1 to 2.8% for BN at T 3 (weighted); the PS-AN and PS-BN prevalence rates range from 0.8% at T 1 to 2.5% at T 3 (weighted). No current cases of AN were observed at any of the assessments, and the rates for current BN did not exceed 0.5%.
First incidence was determined for disorders occurring during childhood/adolescence (i.e., before age 19) and during young adulthood (age 19-23) for the T 3 participants (n = 538). Of interest, there is a decrease in the first incidence of AN from 0-18 through 19-23 (1.3% versus 0.1%, weighted), but relatively little change in BN (1.5% versus 1.3%, weighted). To examine the first incidence rates across the age span, life-table survival analysis was used. The hazard functions for a diagnosis of FS-AN, FS-BN, and FS-ED are shown in Figure 1 . As can be seen, the hazard rates for both AN and BN peak during the 16-17 age interval; the incidence rates drop to prepubertal levels by age 18 for AN and by age 20 for BN.
None of the 16 participants with a lifetime history of eating disorder by age 18 had another episode between ages 19 and 23. There was no comorbidity (concurrent or lifetime) between FS-AN and FS-BN at T 1 or T 2. At T 3, only one participant had a history of AN and BN; the association was not statistically significant. To examine whether PS-ED predicted subsequent onset of FS-ED, we used the subthreshold classification prior to age 19 to predict first incidence during the 19 through 23 age period. The single-incident case of FS-AN did not have PS-AN before age 19; the association was nonsignificant. With respect to the incidence of FS-BN, 2 of the 7 cases were PS-BN before age 19; the association was significant (odds ratio = 12.1, 95% confidence interval = 2.2-67.5).
Comorbidity Between Eating Disorders and Other Psychopathology
Lifetime comorbidity with other disorders was examined at T 2 . To compare the relative prevalence of the other disorders, 3 groups were created: no eating disorder (n = 768), PS-ED (n = 23), and FS-ED (n = 19); because of the small numbers for the eating disorder groups, AN and BN cases were combined. (In preliminary analyses, FS-AN and FS-BN cases did not differ with respect to comorbidity, clinical characteristics, and continuity. These results are available from the first author upon request.) The lifetime prevalence rates for the other disorders are presented in Table 2 . As can be seen, the 2 eating disorder groups were elevated compared with the no-eating disorder group on the aggregate measure of any noneating disorder, depression, and subthreshold bipolar disorder. Compared with the no-eating disorder group, the PS-ED group was elevated on anxiety disorder; the FS-ED group was intermediate. The FS-ED group was elevated on substance abuse/dependence compared with the no-eating disorder group; the PS-ED group was intermediate. ED (n = 23); current diagnosis of major depression or dysthymia at T 2 but no history of FS-or PS-ED (DEP; n = 26); history of nonaffective disorder but no history of FS-ED, PS-ED, or DEP (NAD; n = 73); and no history of disorder (ND; n = 411). Although the comparison with the ND group was considered to provide the most important contrast, to put the results for the FS-ED and PS-ED in a broader perspective, the means and percentages for the participants who were in an episode of depression and those who experienced a nonaffective disorder by T 2 are also presented in Table 3 . Hence, planned contrasts were conducted comparing (1) the FS-ED group with the PS-ED, DEP, NAD, and ND groups; and (2) comparing the PS-ED group with the DEP, NAD, and ND groups.
With respect to demographic characteristics, none of the planned contrasts was statistically significant. Current weight, height, and body mass index (weight [kg]/height [m 2 ]) were contrasted separately for the AN and BN cases. No significant differences were obtained for weight. The FS-BN cases had significantly lower height compared with the NAD and ND groups and had significantly greater body mass compared with the DEP, NAD, ND groups. The FS-ED cases reported a significantly greater number of physical symptoms than the NAD and ND groups. The PS-ED group had a significantly lower number of physical symptoms compared with the DEP group.
With respect to the current GAF score, the FS-ED group had significantly higher functioning compared with the DEP group and significantly lower functioning compared with the ND group. The PS-ED group had significantly lower mean current GAF scores compared with the NAD and ND groups. Both FS-and PS-ED groups differed significantly from the ND group on the previousyear GAF score. Regarding the percentage who received treatment and who attempted suicide, both FS-and PS-ED groups had significantly higher rates compared with the ND group but did not differ from the other comparison groups. With respect to current depression level, the FS-ED group had significantly lower HDRS scores compared with the PS-ED and DEP groups but was significantly elevated compared with the ND group. The PS-ED group had significantly lower HDRS scores compared with the DEP group but had significantly elevated scores compared with the NAD and ND groups. Finally, regarding self-reported depressive symptoms, the FS-ED group reported lower CES-D scores compared with the DEP group but did not differ from the other groups; the PS-ED group had significantly a significantly lower mean CES-D score compared with the DEP group but was elevated compared with the NAD and ND groups.
Continuity Into Young Adulthood
To examine the continuity of psychopathology from childhood (0-18) to young adulthood (19-23), 5 mutually exclusive groups were created on the basis of psychopathology history through age 18 using the following hierarchy: FS-ED (n = 19), PS-ED (n = 24), DEP (n = 207), NAD (n = 83), ND (n = 162). The young adult (age 19-23) period prevalence rates for the psychiatric disorders are presented in Table 4 . Planned contrasts were conducted comparing (1) the FS-ED group to the PS-ED, DEP, NAD, and ND groups; and (2) the PS-ED group to the DEP, NAD, and ND groups. During the 19 through 23 age period, the FS-ED group had an elevated rate of the any-disorder aggregate compared with the ND group; had an elevated rate of FS-ED compared with the DEP, NAD, and ND groups; had a lower rate of PS-ED compared with the PS-ED group; had elevated rates of depression and bipolar disorder compared with the ND group; had an elevated rate of bipolar disorder compared with the DEP group; had an elevated rate of nonaffective disorder compared with the ND groups; and had an elevated rate of antisocial disorder compared with the ND group. The PS-ED had an elevated rate of the any-disorder aggregate compared with the ND group; had an elevated rate of FS-ED compared with the DEP and ND groups; had an elevated rate of PS-ED compared with the DEP, NAD, and ND groups; had an elevated rate of depression compared with the NAD and ND groups; had an elevated rate of bipolar disorder compared with the DEP and ND groups; had a lower rate of nonaffective disorder compared with the NAD group; and had elevated PDE antisocial and borderline personality disorder scores compared with the ND group.
DISCUSSION
Consistent with previous major epidemiological studies conducted in North America (e.g., Garfinkel et al., 1995b) , the lifetime prevalence of AN and BN was low and these disorders were found to be disorders of adolescence. The relatively younger age of onset in AN compared with BN is consistent with reports in the literature. For example, Turnbull et al. (1996) found the highest incidence of AN was for females aged 10 through 19 years, whereas the highest incidence of BN was among females aged 20 through 39. Given that there was only one new case of AN between age 19 and 23 (compared with 7 new cases of bulimia), it appears that the first occurrence of AN takes place almost exclusively during adolescence, whereas risk for onset for BN extends into young adulthood. Our relatively early onset age suggests the possibility that there may be a cohort effect, which would be consistent with other reports (Garfinkel et al., 1995b) .
Most previous studies that have reported psychiatric comorbidity in ED have been based on adult or clinical samples (e.g., Braun et al., 1994; Kendler et al., 1991) . Our very high comorbidity rate-89.5% of participants Note: Diagnostic groups listed in the FS-ED and PS-ED planned contrasts columns indicate a significant difference at p < .05; differences between FS-ED and PS-ED appear only in the FS-ED column. FS-ED = full-syndrome eating disorder; PS-ED = partial-syndrome eating disorder; DEP = major depression or dysthymia; NAD = nonaffective disorder; ND = no disorder. * p < .05; **p < .01; *** p < .001.
with an ED had at least one comorbid lifetime disorder during adolescence-suggests that comorbidity in ED is neither a phenomenon limited to adult and/or patient samples nor simply a consequence of chronicity of the eating disorder. The high rate of comorbidity also makes it impossible to determine the extent to which the negative clinical characteristics associated with ED are due to the comorbid disorder. The high rates of comorbidity with such internalizing disorders as MDD and anxiety disorders provide further evidence that ED fit within the spectrum of internalizing disorders.
In most comparisons, we found that individuals with subthreshold disorder did not differ from FS-ED cases but differed from the no-disorder group. In a position paper on ED in adolescents, the Society for Adolescent Medicine (1995) recommended that for adolescents in particular, a broader definition of ED should be considered because the DSM-IV criteria may not be applicable because during the highly dynamic growth period of adolescence even subsyndromal eating disturbances may be associated with clinically significant health impairment. The clinical significance of PS-ED is illustrated by the substantial comorbidity with other psychiatric disorders, the significantly elevated reports of attempted suicide, and the high rates of prior psychiatric treatment. Moreover, even though most ED cases were not acutely ill at the time of the assessment, PS-ED and FS-ED cases scored significantly lower on global functioning (current, and past year) and were more depressed than the no-disorder group. The finding that on some outcome measures the PS-ED group had scores indicating significantly more pathology than the FS-ED group is consistent with results reported from the Canadian study (Garfinkel et al., 1996) that found PS-AN cases were more symptomatic than FS-AN cases. Our pattern of findings regarding the comparisons of PS-ED with FS-ED is consistent with the notion that ED are spectrum disorders (Striegel-Moore and Marcus, 1995) .
Given that very few participants had experienced a recurrence, it appears that ED in this young sample were relatively circumscribed in time (with clear onset and offset), rather than recurrent or chronic. This finding is in contrast to results based on patient samples in which a protracted course is the norm and recovery has been reported to take years, even among patients who have received state-of-the-art treatment (Strober et al., 1997) . There are several reasons why our sample may have less chronic ED. Our study is based on a community sample and, as mentioned earlier, patient samples are typically biased in the direction of greater pathology. Turnbull et al. (1996) found that the more severe the case, the more likely the patient was referred for treatment. Because there is limited longitudinal information on individuals with an ED who were not recruited through a treatment study, the natural course of ED among women in the community is unknown. Clearly, our results need to be replicated; perhaps with longer follow-up, some will relapse. In spite of the relatively short episode duration of ED in our study, the high rates of psychiatric comorbidity in our ED sample suggest that while the eating disorder may have been relatively short in duration, individuals who meet diagnostic criteria for partial-or full-syndrome AN or BN also experience clinically significant psychiatric impairment which may last much longer.
Clinical Implications
There are 2 overarching clinical implications. First, even though ED are relatively rare, the impact on health and mental health of these disorders is considerable. Our data show high rates of psychiatric comorbidity and lasting effects on psychosocial functioning even when the acute episode of the ED has remitted. Second, screening for FS-and PS-ED should be a routine part of the medical assessment of adolescent girls. Such screening is especially indicated among adolescents who are known to have another psychiatric disorder. Our findings suggest that comprehensive diagnostic assessment of adolescents presenting eating problems should probe for the existence of depression, anxiety, and substance use disorders.
Limitations
Only a relatively small number of AN and BN cases were identified, raising concern about adequate power to detect meaningful effects. This is a challenge common to community-based studies of ED, and independent crossvalidation needs to be stressed. Furthermore, combining AN and BN cases was not ideal and limits the interpretation of the results. In addition, numerous tests were performed, thereby inflating the potential for type I error; taking the low power into consideration, more conservative adjustments to the α level were not made.
However, despite these concerns, several strengths can be noted. Few studies have examined ED in communitybased samples of adolescents even though, as our data confirm, onset of ED occurs during adolescence. Another strength is that our study provides systematic data, including comorbidity and natural course, on partial syndromes.
Our data suggest that ED and their partial syndrome variants are associated with considerable comorbidity, high rates of treatment utilization, considerable risk for suicide, and, even when remitted, elevated rates of somatic symptoms and impaired functioning.
